Synthetic biologists have created a slow-growing version of the coronavirus to give as a vaccine The news: Synthetic biology has led to a way to create a weakened form of the coronavirus that causes covid-19. Although the idea remains a long-shot in the vaccine race, an attenuated coronavirus could be formulated into inexpensive nose drops for use around the world. Plans are for the first volunteers to sniff up the synthetically designed virus starting in November, in initial human safety tests in the UK. What's the difference? The most advanced covid vaccine candidates expose a person to only one part of the virus, the crown-shaped “spike” that gives it its name, in order to generate antibodies. The potential advantage of a vaccine using an attenuated live strain is that the body will encounter—and be able to react to—the entire virus. People will “catch” it through their nose, and it will even grow inside them. In theory, that could prompt the formation of not just antibodies but also T cells and specialized forms of immunity in the nasal passage, leading to broader protection. Take it slow: The engineered virus looks exactly the same as the real thing on the outside but has a “virtual brake pedal” inside, causing it to replicate much less quickly. Inside a person, it could be less efficient by a factor of up to 1,000, giving the immune system time to respond. Long history: It might seem scary to imagine getting infected by the coronavirus on purpose, but attenuated-virus vaccines are common. The kids’ flu vaccine FluMist has a weakened influenza virus in it. The only disease ever successfully eradicated from the globe, smallpox, was wiped out with shots of a live virus. However, not all experts believe this is the right approach. Read the full story. —Antonio Regalado
|